Education and Training
MD - Yale University School of Medicine, New Haven, CT
Pediatrics - Boston Children's Hospital & Boston City Hospital, Boston, MA
Pediatrics - Boston Children's Hospital & Boston City Hospital, Boston, MA (Chief Resident)
Neonatal-Perinatal Medicine - The Children's Hospital of Philadelphia, Philadelphia, PA
PhD in Genetics - Yale University School of Medicine, New Haven, CT
MS in Clinical Epidemiology and Biostatistics (MSCE) - University of Pennsylvania, Philadelphia, PA
Titles and Academic Titles
Attending Neonatologist, Pennsylvania Hospital
Associate Professor of Clinical Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Departments and Services
Salaets Thomas, Turner Mark A, Short Mary, Ward Robert M, Hokuto Isamu, Ariagno Ronald L, Klein Agnes, Beauman Sandra, Wade Kelly, Thomson Merran, Roberts Eve, Harrison Judy, Quinn Theresa, Baer Gerri, Davis Jonathan, Allegaert Karel: Development of a neonatal adverse event severity scale through a Delphi consensus approach. Archives of disease in childhood 104(12): 1167-1173, Dec 2019.
Puia-Dumitrescu Mihai, Smith P Brian, Zhao Jian, Soriano Angela, Payne Elizabeth H, Harper Barrie, Bendel-Stenzel Ellen, Moya Fernando, Chhabra Rakesh, Ku Lawrence, Laughon Matthew, Wade Kelly C: Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants. Pediatrics 211(1): 27-32, Aug 2019.
Gerhart Jacqueline G, Watt Kevin M, Edginton Andrea, Wade Kelly C, Salerno Sara N, Benjamin Daniel K, Smith P Brian, Hornik Christoph P, Cohen-Wolkowiez Michael, Duara Shahnaz, Ross Ashley, Shattuck Karen, Stewart Dan L, Neu Natalie, Gonzalez Daniel: Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants. CPT: pharmacometrics & systems pharmacology 8(7): 500-510, Jul 2019.
Wade Kelly C, Ying Gui-Shuang, Baumritter Agnieshka, Gong Alice, Kemper Alex R, Quinn Graham E: Factors in Premature Infants Associated with Low Risk of Developing Retinopathy of Prematurity. JAMA ophthalmology 137(2): 160-166, Nov 2018.
Hwang MF, Beechinor RJ, Wade KC, Benjamin DK Jr, Smith PB, Hornik CP, Capparelli EV, Duara S, Kennedy KA, Cohen-Wolkowiez M, Gonzalez D. External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models. Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01352-17. doi: 10.1128/AAC.01352-17. [Epub ahead of print]
Kemper AR, Wade KC, Hornik CP, Ying GS, Baumritter A, Quinn GE; Telemedicine Approaches to Evaluating Acute-phase Retinopathy of Prematurity (e-ROP) Study Cooperative Group. Retinopathy of prematurity risk prediction for infants with birth weight less than 1251 grams. J Pediatr. 2015 Feb;166(2):257-261.e2. doi: 10.1016/j.jpeds.2014.09.069. Epub 2014 Nov 12.
Monk HM, Motsney AJ, Wade KC. Safety of Rotavirus Vaccine in the NICU. J Pediatr. 2014 May 19. [Epub ahead of print]
Cohen-Wolkowiez M. Poindexter B., Bidegain M. Weitkamp J.H. Schleonka R.L., Randolph D.A., Ward R.M., Wade K., Valencia G., Burchfield D., Arrieta A., Mehta V., Walsh M., Kantak A., Rasmussen M., Sullivan J.E., Finer N., Rich W., Brozansi B.S., van den Anker J., Blumer J., Laughon M., Watt K.M., Kearns G.L., Capparelli E.V., Martz K., Berezny K., Benjamin D.K. Jr, Smith P.B.; Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections. Clinical Infectious Disease 55(11): 1495, Dec 2012.
Watt K.M., Benjamin O.K. Jr, Cheifetz I.M., Moorthy G., Wade K.C., Smith P.B., Brouwer K.L., Capparelli E.V., Cohen-Wolkowietz M.: Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation. Pediatric Infectious Disease Journal 31(10): 1042-7, Oct 2012.
Mossabeb R, Wade K.C., Finnegan K., Sivieri E., Abbasi S.: Language development survey provides a useful screening tool for language delay in preterm infants. Clinical Pediatrics 51(7): 638, July 2012.
Smith P.B., Cohen-Wolkowiez M., Castro L.M., Poindexter B., Bidegain M., Weitkamp J.H., Schelonka RL., Ward R.M., Wade K., Valencia G., Burchfield D., Arrieta A, Bhatt-Mehta V., Walsh M., Kantak A, Rasmussen M., Sullivan J.E., Finer N., Brozanski B.S., Sanchez P., van den Anker J., Blumer J., Keams G.L., Capparelli E.V., Anand R, Benjamin D.K.: Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections. Pediatric Infectious Disease Journal 30(10): 844, Oct 2011.
Laughon M.M., Benjamin D.K., Capparelli E.V., Keams G.L., Berezny K., Paul I.M., Wade K., Barrett J., Smith P.B., Cohen-Wolkowiez M.: Innovative clinical trial design for pediatric therapeutics. Expert Review of Clinical Pharmacology 4(5): 643-52, Sep 2011.
Piper L., Smith P.B., Hornik C.P., Cheifetz I.M., Barrett J.S., Moorthy G., Hope W.W., Wade K.C., Cohen-Wolkowiez M., Benjamin D.K.: Fluconazole loading dose pharmacokinetics and safety in infants. Pediatric Infectious Disease Journal 30(5): 375, May 2011.
Wade K.C., Ellenberg J.H., Grosser T., Brensinger C.M., Kimmel S.E., Hennessy S.: Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women. Journal Cardiovascular Pharmacology 57(2): 194, Feb 2011.
Posters and Presentations
Monk H and Wade K.C. : Safety of Rotavirus Vaccine Administration Among Infants Within the Newborn/Infant Intensive Care Unit. Platform Presentation. Pediatric Academic Society Annual Meeting; 2012 April 28 - May 1; Boston MA.
Aliaga S., Smith P.B., Clark R., Cohen-Wolkowiez M., Wade K., Massie S., Tolleson-Rinehart S., Benjamin D.K., Laughon M.: Assessment of off-label prescribing practices of meropenem in young infants. Pediatric Academic Society Annual Meeting; 2011 April 30 - May 3; Denver, CO.
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.